EP 4125876 A1 20230208 - NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT
Title (en)
NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT
Title (de)
NEUE THERAPEUTISCHE ZIELMOLEKÜLE MIT ANTI-INFLAMMATORISCHER UND ANTI-INTERFERON-WIRKUNG
Title (fr)
NOUVELLES CIBLES THÉRAPEUTIQUES À EFFET ANTI-INFLAMMATOIRE ET ANTI-INTERFÉRON
Publication
Application
Priority
- FR 2003087 A 20200327
- EP 2021058039 W 20210326
Abstract (en)
[origin: WO2021191455A1] The invention relates to an inhibitor of the ROCK-PDK1 protein kinase complex for use as an anti-inflammatory and anti-interferon agent. The present invention also relates to a pharmaceutical composition containing an inhibitor of the ROCK-PDK1 protein kinase complex as an active ingredient and at least one pharmaceutically acceptable excipient and/or carrier and/or diluent and/or a pharmaceutically acceptable vehicle. The invention also relates to the use of said pharmaceutical composition in the prevention and/or treatment of inflammatory diseases, viral and/or bacterial infections and autoimmune diseases.
IPC 8 full level
A61K 9/00 (2006.01); A61K 31/404 (2006.01); A61K 31/4412 (2006.01); A61K 31/4439 (2006.01); A61K 31/506 (2006.01); A61K 45/06 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP US)
A61K 31/4409 (2013.01 - EP US); A61K 31/551 (2013.01 - EP US); A61K 45/06 (2013.01 - EP); A61P 19/02 (2017.12 - US); A61P 29/00 (2017.12 - EP US); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/06 (2017.12 - US); A61P 43/00 (2017.12 - EP); A61K 9/0014 (2013.01 - EP); A61K 9/0019 (2013.01 - EP); Y02A 50/30 (2017.12 - EP)
Citation (search report)
See references of WO 2021191455A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021191455 A1 20210930; EP 4125876 A1 20230208; EP 4125889 A1 20230208; FR 3108501 A1 20211001; US 2023124142 A1 20230420; WO 2021191460 A1 20210930
DOCDB simple family (application)
EP 2021058039 W 20210326; EP 2021058052 W 20210326; EP 21713711 A 20210326; EP 21713991 A 20210326; FR 2003087 A 20200327; US 202117907305 A 20210326